Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal M Lavoie

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Infectious Diseases|May 7, 2022
Waning Immunity Against Respiratory Syncytial Virus During the Coronavirus Disease 2019 PandemicFrederic Reicherz, Rui Yang Xu, Bahaa Abu-Raya, et al.
BMJ Open|July 30, 2023
Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysisIsabelle Marc, Pascal M Lavoie, Andrew J McPhee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 18, 2009
Neonatal innate TLR-mediated responses are distinct from those of adultsTobias R Kollmann, Juliet Crabtree, Annie Rein-Weston, et al.
Microbiology Spectrum|September 19, 2022
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated IndividualsBrian Grunau, Martin Prusinkiewicz, Michael Asamoah-Boaheng, et al.
Microbiology Spectrum|July 21, 2022
Symptomatic and Asymptomatic Transmission of SARS-CoV-2 in K-12 Schools, British Columbia, Canada April to June 2021Alexandra Choi, Louise C Mâsse, Samantha Bardwell, et al.
PLOS Global Public Health|August 7, 2024
The epidemiology and risk factors for postnatal complications among postpartum women and newborns in southwestern Uganda: A prospective cohort studyYashodani Pillay, Joseph Ngonzi, Vuong Nguyen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 28, 2025
Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort studyVictoria G Hall, Adrian A Alexander, Faranak Mavandadnejad, et al.
Frontiers in Epidemiology|March 8, 2024
Prognostic algorithms for post-discharge readmission and mortality among mother-infant dyads: an observational study protocolMatthew O Wiens, Jessica Trawin, Yashodani Pillay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing IntervalBrian Grunau, Michael Asamoah-Boaheng, Pascal M Lavoie, et al.
BMJ Open|June 12, 2023
SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, CanadaAllison W Watts, Louise C Mâsse, David M Goldfarb, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Infectious Diseases|May 7, 2022
Waning Immunity Against Respiratory Syncytial Virus During the Coronavirus Disease 2019 PandemicFrederic Reicherz, Rui Yang Xu, Bahaa Abu-Raya, et al.
BMJ Open|July 30, 2023
Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysisIsabelle Marc, Pascal M Lavoie, Andrew J McPhee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 18, 2009
Neonatal innate TLR-mediated responses are distinct from those of adultsTobias R Kollmann, Juliet Crabtree, Annie Rein-Weston, et al.
Microbiology Spectrum|September 19, 2022
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated IndividualsBrian Grunau, Martin Prusinkiewicz, Michael Asamoah-Boaheng, et al.
Microbiology Spectrum|July 21, 2022
Symptomatic and Asymptomatic Transmission of SARS-CoV-2 in K-12 Schools, British Columbia, Canada April to June 2021Alexandra Choi, Louise C Mâsse, Samantha Bardwell, et al.
PLOS Global Public Health|August 7, 2024
The epidemiology and risk factors for postnatal complications among postpartum women and newborns in southwestern Uganda: A prospective cohort studyYashodani Pillay, Joseph Ngonzi, Vuong Nguyen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 28, 2025
Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort studyVictoria G Hall, Adrian A Alexander, Faranak Mavandadnejad, et al.
Frontiers in Epidemiology|March 8, 2024
Prognostic algorithms for post-discharge readmission and mortality among mother-infant dyads: an observational study protocolMatthew O Wiens, Jessica Trawin, Yashodani Pillay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing IntervalBrian Grunau, Michael Asamoah-Boaheng, Pascal M Lavoie, et al.
BMJ Open|June 12, 2023
SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, CanadaAllison W Watts, Louise C Mâsse, David M Goldfarb, et al.
Pageof 15